Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-18

Clinical Trial Update: Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares amantadine to methylphenidate (Ritalin) for Attention Deficit Hyperactivity Disorder, sponsored by Tehran University of Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)
  • amantadine (amantadine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: UNKNOWN